{"id":54342,"date":"2025-01-09T11:14:53","date_gmt":"2025-01-09T11:14:53","guid":{"rendered":"https:\/\/www.innovationnewsnetwork.com\/?p=54342"},"modified":"2025-01-09T11:14:53","modified_gmt":"2025-01-09T11:14:53","slug":"exeter-launches-second-round-of-funding-to-tackle-antifungal-drug-resistance","status":"publish","type":"post","link":"https:\/\/www.innovationnewsnetwork.com\/exeter-launches-second-round-of-funding-to-tackle-antifungal-drug-resistance\/54342\/","title":{"rendered":"Exeter launches second round of funding to tackle antifungal drug resistance"},"content":{"rendered":"
The FAILSAFE project (Fungal AMR Innovations for LMICS: Solutions and Access For Everyone) is a groundbreaking initiative tackling antifungal drug resistance (fAMR).<\/p>\n
The project aims to promote worldwide innovations to tackle the global health threat of fungal infections in humans, plants, and animals, which are increasingly resistant to available treatment.<\/p>\n
The FAILSAFE project has already awarded more than \u00a31.7m in grants to 78 researchers across 13 countries. The scheme focuses on developing innovative solutions for antifungal drug resistance, a critical global health issue disproportionately affecting low- and middle-income countries (LMICs).<\/p>\n
To deliver FAILSAFE, the UK Government\u2019s Global Antimicrobial Resistance Innovation Fund (GAMRIF) programme is partnering with the University of Exeter\u2019s MRC Centre for Medical Mycology (MRC CMM).<\/p>\n
The world-leading Centre\u2019s overarching mission is to deliver research that will substantially advance our understanding of fungal diseases and improve the prevention, diagnosis, and treatment of fungal diseases in the future.<\/p>\n
Antifungal drug resistance poses a critical threat to both human health and global food security. Fungal infections can be devastating, particularly for vulnerable individuals such as children with leukaemia and those with compromised immune systems.<\/p>\n
In addition to increasing the number of deaths due to fungal diseases, drug-resistant fungal pathogens also jeopardise wildlife and essential crops that sustain the global food supply<\/a>.<\/p>\n Life-threatening fungal diseases claim as many lives annually as tuberculosis or malaria, yet the organisms responsible remain significantly understudied, and the arsenal of effective treatments is critically limited.<\/p>\n The escalating prevalence of antifungal drug resistance in the environment and hospital settings further diminishes treatment options, thereby intensifying this urgent crisis.<\/p>\nTransforming outcomes<\/h3>\n